Atlas Trials

Study to Asses Efficacy of Intralymphatic Immunotherapy

Clinical trial NCT01166269 · COMPLETED

Trial details

NCT number
NCT01166269
Sponsor
Rigshospitalet, Denmark
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Allergy
Start date
2010-07-01
Primary completion
2012-11-01
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.